The Enterprise Value as of September 2024 (TTM) for MEI Pharma, Inc. (MEIP) is 29.55M

According to MEI Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 29.55M. This represents a change of -32.84% compared to the average of 44.01M of the last 4 quarters.

MEI Pharma, Inc. (MEIP) Historical Enterprise Value (quarterly & annually)

How has MEIP Enterprise Value performed in the past?

The mean historical Enterprise Value of MEI Pharma, Inc. over the last ten years is 137.18M. The current 29.55M Enterprise Value has changed 2.05% with respect to the historical average. Over the past ten years (40 quarters), MEIP's Enterprise Value was at its highest in in the June 2020 quarter at 422.18M. The Enterprise Value was at its lowest in in the September 2020 quarter at 18.13M.

MEI Pharma, Inc. (MEIP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MEI Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MEI Pharma, Inc. (MEIP) Average Enterprise Value

How has MEIP Enterprise Value performed in the past?

The current Enterprise Value of MEI Pharma, Inc. (MEIP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MEI Pharma, Inc. (MEIP) Enterprise Value vs. Peers

How is MEIP’s Enterprise Value compared to its peers?

MEI Pharma, Inc.’s Enterprise Value is greater than Magenta Therapeutics, Inc. (-114170976.00), less than Kezar Life Sciences, Inc. (30.94M), greater than Vincerx Pharma, Inc. (15.55M), greater than Avenue Therapeutics, Inc. (-918349.00), less than Assembly Biosciences, Inc. (95.68M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Instil Bio, Inc. (507.44M), less than CytomX Therapeutics, Inc. (63.41M), greater than Achilles Therapeutics plc (-61656377.00), less than Ocular Therapeutix, Inc. (981.07M), greater than Spero Therapeutics, Inc. (14.38M), less than Acumen Pharmaceuticals, Inc. (113.46M), less than HOOKIPA Pharma Inc. (94.99M), less than Day One Biopharmaceuticals, Inc. (969.12M), less than Inozyme Pharma, Inc. (408.20M), less than Terns Pharmaceuticals, Inc. (573.42M), greater than Revelation Biosciences, Inc. (-10569356.00), less than Zura Bio Limited (43.06M), greater than Phio Pharmaceuticals Corp. (-1900743.00), greater than ZyVersa Therapeutics, Inc. (2.43M), greater than TransCode Therapeutics, Inc. (1.37M),

Build a custom stock screener for MEI Pharma, Inc. (MEIP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MEI Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MEI Pharma, Inc. (MEIP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MEI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.